These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17016434)

  • 1. The activation of TC10, a Rho small GTPase, contributes to v-Rel-mediated transformation.
    Tong S; Liss AS; You M; Bose HR
    Oncogene; 2007 Apr; 26(16):2318-29. PubMed ID: 17016434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of changes in gene expression associated with malignant transformation by the NF-kappaB family member, v-Rel.
    Petrenko O; Ischenko I; Enrietto PJ
    Oncogene; 1997 Oct; 15(14):1671-80. PubMed ID: 9349500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of v-Rel oncogene-induced inhibitor of apoptosis by differential display.
    You M; Bose HR
    Methods; 1998 Dec; 16(4):373-85. PubMed ID: 10049645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the rel-homology domain alter the biochemical properties of v-rel and render it transformation defective in chicken embryo fibroblasts.
    Morrison LE; Boehmelt G; Enrietto PJ
    Oncogene; 1992 Jun; 7(6):1137-47. PubMed ID: 1594245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The suppression of SH3BGRL is important for v-Rel-mediated transformation.
    Majid SM; Liss AS; You M; Bose HR
    Oncogene; 2006 Feb; 25(5):756-68. PubMed ID: 16186799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of v-rel in a replication competent virus: transformation and biochemical characterization.
    Morrison LE; Boehmelt G; Beug H; Enrietto PJ
    Oncogene; 1991 Sep; 6(9):1657-66. PubMed ID: 1656369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the TGF-β/Smad signaling pathway in oncogenic transformation by v-Rel.
    Tiwari R; Bargmann W; Bose HR
    Virology; 2011 Apr; 413(1):60-71. PubMed ID: 21345476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PIST: a novel PDZ/coiled-coil domain binding partner for the rho-family GTPase TC10.
    Neudauer CL; Joberty G; Macara IG
    Biochem Biophys Res Commun; 2001 Jan; 280(2):541-7. PubMed ID: 11162552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TOJ3, a target of the v-Jun transcription factor, encodes a protein with transforming activity related to human microspherule protein 1 (MCRS1).
    Bader AG; Schneider ML; Bister K; Hartl M
    Oncogene; 2001 Nov; 20(51):7524-35. PubMed ID: 11709724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The v-rel oncogene encodes a cell-specific transcriptional activator of certain promoters.
    Gélinas C; Temin HM
    Oncogene; 1988 Oct; 3(4):349-55. PubMed ID: 2856247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel.
    Gilmore TD; Cormier C; Jean-Jacques J; Gapuzan ME
    Oncogene; 2001 Oct; 20(48):7098-103. PubMed ID: 11704834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant envelope residues confer a transactivation function onto N-terminal sequences of the v-Rel oncoprotein.
    Epinat JC; Kazandjian D; Harkness DD; Petros S; Dave J; White DW; Gilmore TD
    Oncogene; 2000 Feb; 19(5):599-607. PubMed ID: 10698504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A chicken c-Rel-estrogen receptor chimeric protein shows conditional nuclear localization, DNA binding, transformation and transcriptional activation.
    Zurovec M; Petrenko O; Roll R; Enrietto PJ
    Oncogene; 1998 Jun; 16(24):3133-42. PubMed ID: 9671392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription factor ATF3 partially transforms chick embryo fibroblasts by promoting growth factor-independent proliferation.
    Perez S; Vial E; van Dam H; Castellazzi M
    Oncogene; 2001 Mar; 20(9):1135-41. PubMed ID: 11314051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of tumor necrosis factor alpha-responsive serine residues within the C-terminal transactivation domain of human transcription factor REL enhance its in vitro transforming ability.
    Starczynowski DT; Reynolds JG; Gilmore TD
    Oncogene; 2005 Nov; 24(49):7355-68. PubMed ID: 16027730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the carboxy terminus of v-Rel in transformation and activation of endogenous gene expression.
    Smardova J; Walker A; Morrison LE; Kabrun N; Enrietto PJ
    Oncogene; 1995 May; 10(10):2017-26. PubMed ID: 7761102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping of the functional domains of the v-rel oncogene.
    Garson K; Kang CY
    Oncogene; 1990 Sep; 5(9):1431-4. PubMed ID: 2216467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GTP hydrolysis by the Rho family GTPase TC10 promotes exocytic vesicle fusion.
    Kawase K; Nakamura T; Takaya A; Aoki K; Namikawa K; Kiyama H; Inagaki S; Takemoto H; Saltiel AR; Matsuda M
    Dev Cell; 2006 Sep; 11(3):411-21. PubMed ID: 16950130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Envelope-dependent transactivation by the retroviral oncoprotein v-Rel is required for efficient malignant transformation of chicken spleen cells.
    Epinat JC; Dvorin EL; Gilmore TD
    Oncogene; 2000 Jun; 19(28):3131-7. PubMed ID: 10918567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel.
    Gilmore TD
    Oncogene; 1999 Nov; 18(49):6925-37. PubMed ID: 10602467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.